Advancing COPD management through novel pharmacological agents: ensifentrine and dupilumab.
Saved in:
| Title: | Advancing COPD management through novel pharmacological agents: ensifentrine and dupilumab. |
|---|---|
| Authors: | Walkon LL; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA., Burmeister JR; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA., Nazmifar M; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA., Bohler F; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA., Kochanowska-Karamyan A; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA., Allen SA; Pulmonology Critical Care Medicine, Corewell Health Beaumont Troy Hospital, Troy, MI, USA. |
| Source: | Breathe (Sheffield, England) [Breathe (Sheff)] 2025 Dec 16; Vol. 21 (4), pp. 250206. Date of Electronic Publication: 2025 Dec 16 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: European Respiratory Society Country of Publication: England NLM ID: 101231007 Publication Model: eCollection Cited Medium: Print ISSN: 1810-6838 (Print) Linking ISSN: 18106838 NLM ISO Abbreviation: Breathe (Sheff) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
